Syntara Interim Phase II Data SNT 5505,,,, SH Predictions......, page-7

Normally I would agree with you on your analogy ,,except ,,, this data is being presented to 30,000 Oncology Specialists, World Media, Fund managers and Big Pharma.

Again this is a Keynote Speaker Engagement, mainstage event ,, not a mere exhibitor...

We could be about to see something incredible ,,, I've been in Biotech for over 20 years and the stars look to be aligning here at SNT...

plus this is the first of 4 x Phase II Candidates...
Parkinsons in the UK , funded with a Grant
SNT 6302 with Prof Fiona Woods already using the Treatment on Burns Grafts ,,,,